EXHIBIT 11
HemaCare Corporation
Net Income (Loss) per Common and Common Equivalent Share
Three Months Ended | Nine Months Ended | ||||||||||||
September 30, | September 30, | ||||||||||||
2007 | 2006 | 2007 | 2006 | ||||||||||
BASIC | |||||||||||||
Weighted average common shares used to compute basic earnings per share | 8,794,000 | 8,298,000 | 8,588,000 | 8,162,000 | |||||||||
Net income (loss) | $ | (5,596,000 | ) | $ | 448,000 | $ | (6,356,000 | ) | $ | 893,000 | |||
Basic net income (loss) per share | $ | (0.64 | ) | $ | 0.05 | $ | (0.74 | ) | $ | 0.11 | |||
DILUTED | |||||||||||||
Weighted average common shares used to compute basic earnings per share | 8,794,000 | 8,298,000 | 8,588,000 | 8,162,000 | |||||||||
Dilutive common equivalent shares attributable to stock options (based on average market price) | - | 806,000 | - | 819,000 | |||||||||
Dilutive common equivalent shares attributable to warrants (based on average market price) | - | - | |||||||||||
Weighted average common shares used to compute diluted earnings per share | 8,794,000 | 9,104,000 | 8,588,000 | 8,981,000 | |||||||||
Net income (loss) | $ | (5,596,000 | ) | $ | 448,000 | $ | (6,356,000 | ) | $ | 893,000 | |||
Dilutive net income (loss) per share | $ | (0.64 | ) | $ | 0.05 | $ | (0.74 | ) | $ | 0.10 |